Hyunsun Jo
CEO Pin Therapeutics
Founder and Chief Executive Officer of Pin Therapeutics, Korea (2017-)
Founding Partner of Embedbio (The Early-Stage Investment Company Builder Specialized in Biotech and Healthcare Sectors), Palo Alto, CA, USA
Postdoctoral Fellow of Medicine, J David Gladstone Institute (UCSF), CA, USA
PhD of Biological Sciences, Seoul National University (Metabolic Diseases), Korea
Bachelor of Chemistry, Seoul National University, Korea
Bachelor of Biological Sciences, Seoul National University, Korea
Seminars
Thursday 11th June 2026
Panel Discussion: Navigating Venture Capital Funding & Structuring Strategic Collaborations in South Korea to Accelerate Biotech Growth, Secure Investment & Expand Global Reach
9:00 am
- Understanding venture capital expectations in Korea, China and Japan to tailor fundraising strategies, attract sufficient capital and enable sustainable scaling of your biotech
- Examining how early-stage proof-of-concept studies validate technology, strengthen investor confidence, and accelerate pharma partnership commitments
- Discussing how to structure successful biotech–pharma–academia collaborations in South Korea, Japan and China to balance expectations and maximize the translational speed of your TPD candidate
- What does the future hold for the TPD field? What are the emerging modalities and where do you think they are they headed?
Thursday 11th June 2026
Harnessing Novel Biology with a Next-Generation E3 Ligase in Targeted Protein Degradation
11:30 am
- Outlining insights from novel ligase discovery to degrader development
- Examining the biological differentiation beyond conventional CRBN and VHL E3 ligases
- Outlining how to enable safer degraders through reduced hematologic toxicity and improved therapeutic index
